Paola Volpicelli

“Real-life” results of front-line treatment with Imatinib in older patients (≥65 years) with newly diagnosed chronic myelogenous leukemia

Roberto Latagliata, Massimo Breccia, Ida Carmosino et al. · Leukemia Research · 2010 · 55 citations

Hematological Malignancy, Oncology, Older Patients +8

Twice-Weekly High-Dose rHuEpo for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndromes

Roberto Latagliata, Esther N. Oliva, Paola Volpicelli et al. · Acta Haematologica · 2008 · 19 citations

Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib

Roberto Latagliata, Paola Volpicelli, Massimo Breccia et al. · American Journal of Hematology · 2014 · 16 citations · Full text

Anemia, Hematological Malignancy, Chronic Myeloid Leukemia +14

Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response

Roberto Latagliata, Angela Romano, Marco Mancini et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 16 citations · Full text

Hematological Malignancy, Chronic Myeloid Leukemia, Alpha-interferon Treatment +15

<scp>TPO</scp>‐<scp>RA</scp>s in <scp>pITP</scp>: description of a case series and analysis of predictive factors for response

Maria Gabriella Mazzucconi, Cristina Santoro, Erminia Baldacci et al. · European Journal Of Haematology · 2016 · 16 citations